EUVIMEDEUVIMED entdecken
Vergleichsstudie

Differential expression of survivin and its splice variants, survivin-ΔEx3 and survivin-2B, in bladder cancer

Yaser Atlasi, Seyed Javad Mowla, Seyed Amir-Mohsen Ziaee

Cancer Detection and Prevention · 2009-01 · 32 (4) · 308-313

DOI: 10.1016/j.cdp.2008.12.001 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Cancer Detection and Prevention, 2009-01. Verfasst von Yaser Atlasi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Faculty of Basic Sciences, Tarbiat Modares University, P.O. Box 14115-175 Tehran, Iran. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Survivin, an inhibitor of apoptosis protein (IAP), has been regarded as a valuable tumor marker for diagnosis and prognosis of bladder cancer. Recently, three splice variants of the gene with different anti-apoptotic activities have been reported. However, there is no data on the expression and potential causative roles of these transcripts in bladder cancer. Here, we have investigated the expression pattern of survivin and two of its splice variants, survivin-DeltaEx3 and survivin-2B, in malignant versus non-malignant bladder tissues. METHODS: We used semi-quantitative RT-PCR analysis to examine the expression of survivin variants in 30 transitional cell carcinoma, 19 matched non-tumor, and 9 apparently healthy control tissue samples of the bladder. DNA sequencing was used to confirm the identity of amplified fragments. RESULTS: For all examined samples, survivin was the predominant transcript, being present in 83% of tumor and 25% of non-tumor bladder tissue samples, and survivin-2B was the least detected isoform. The expression levels of survivin and survivin-DeltaEx3 was significantly higher in neoplastic compared to non-neoplastic tissues (P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alternative SplicingApoptosis Regulatory ProteinsCarcinoma, Transitional CellGenetic VariationHumansInhibitor of Apoptosis ProteinsMicrotubule-Associated ProteinsNeoplasm InvasivenessNeoplasm ProteinsProtein IsoformsSurvivinUrinary Bladder Neoplasms

Substanzen

Apoptosis Regulatory ProteinsBIRC5 protein, humanInhibitor of Apoptosis ProteinsMicrotubule-Associated ProteinsNeoplasm ProteinsProtein IsoformsSurvivin

Autor:innen und Institutionen

  • Department of Genetics, Faculty of Basic Sciences, Tarbiat Modares University, P.O. Box 14115-175 Tehran, Iran.

Zitieren

APA

Atlasi, Y., Mowla, S. J., & Ziaee, S. A. (2009). Differential expression of survivin and its splice variants, survivin-ΔEx3 and survivin-2B, in bladder cancer. Cancer Detection and Prevention, 32(4), 308-313. https://doi.org/10.1016/j.cdp.2008.12.001

Vancouver

Atlasi Y, Mowla SJ, Ziaee SA. Differential expression of survivin and its splice variants, survivin-ΔEx3 and survivin-2B, in bladder cancer. Cancer Detection and Prevention. 2009;32(4):308-313. doi:10.1016/j.cdp.2008.12.001

BibTeX
@article{Atlasi2009,
  author = {Atlasi, Yaser and Mowla, Seyed Javad and Ziaee, Seyed Amir-Mohsen},
  title = {Differential expression of survivin and its splice variants, survivin-ΔEx3 and survivin-2B, in bladder cancer},
  journal = {Cancer Detection and Prevention},
  year = {2009},
  volume = {32},
  number = {4},
  pages = {308--313},
  doi = {10.1016/j.cdp.2008.12.001}
}
Kostenlos starten →